0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Diabetes Management Market by Device Type, Technology, End User, Deployment Mode, Type, Component - Global Forecast 2025-2030- Product Image
Artificial Intelligence in Diabetes Management Market by Device Type, Technology, End User, Deployment Mode, Type, Component - Global Forecast 2025-2030- Product Image
Sale

Artificial Intelligence in Diabetes Management Market by Device Type, Technology, End User, Deployment Mode, Type, Component - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904643
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Artificial intelligence is redefining how diabetes is managed, empowering care teams to personalize interventions, minimize manual error, and improve patient engagement through advanced analytics. Senior stakeholders considering investment or strategic expansion in this sector will find actionable insights in this comprehensive executive summary.

Market Snapshot: Artificial Intelligence in Diabetes Management Market

The Artificial Intelligence in Diabetes Management Market grew from USD 1.00 billion in 2024 to USD 1.32 billion in 2025. It is expected to continue growing at a CAGR of 30.79%, reaching USD 5.04 billion by 2030. Market expansion is propelled by the integration of AI technologies with continuous glucose monitoring, automated insulin delivery, and advanced decision support platforms. These innovations support clinicians, enhance real-time treatment, and optimize outcomes for various patient populations across major global regions.

Scope & Segmentation Overview

  • Device Types: Blood glucose meters (including non-invasive and self-monitoring), closed loop systems (fully and hybrid models), continuous glucose monitors (real-time and intermittently scanned), and insulin pumps (patch and tubed variants).
  • Technologies: Cloud computing (private and public options); decision support systems (alert generation and dose recommendations); machine learning approaches (reinforcement, supervised, and unsupervised); mobile applications (Android and iOS platforms); predictive analytics for glucose trend and risk assessment.
  • End Users: Clinics (diabetes centers, general clinics), hospitals (inpatient, outpatient), home care (remote and self-monitoring), and research institutes (academic and private).
  • Deployment Modes: Cloud-based solutions (hybrid and public cloud), on-premise deployments (edge computing, server-based).
  • Diabetes Types: Gestational (all trimesters), type 1 (juvenile and adult onset), and type 2 (insulin-dependent and non-insulin-dependent).
  • Component Types: Hardware (pumps, sensors, wearable devices) and software (algorithms, data management, user interface frameworks).
  • Geographical Coverage: Americas, Europe, Middle East & Africa, Asia-Pacific, including in-depth regional breakdowns and major countries in each area.
  • Company Coverage: Profiling of key industry leaders such as Medtronic plc, Abbott Laboratories, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Insulet Corporation, Tandem Diabetes Care, and others.

Key Takeaways for Senior Decision-Makers

  • AI-powered tools are systematically shifting care from episodic testing toward real-time, continuous glucose monitoring, enhancing insight generation and patient adherence.
  • Closed loop systems, combined with patient-friendly mobile interfaces, are reducing manual intervention and paving the way for preventive diabetes management.
  • Data interoperability and cross-device integration are strengthening healthcare providers’ ability to deliver coordinated, patient-centric solutions.
  • Regional strategies are essential: North America leads in digital infrastructure, EMEA leverages regulatory harmonization for cross-border innovation, and Asia-Pacific is expanding access through localized partnerships and high-growth initiatives.
  • Collaborative ecosystems blending device manufacturers, software developers, and cloud service providers are driving product advancements and scalability.
  • Technology segmentation and deployment flexibility ensure tailored approaches for hospitals, clinics, and home care environments, adapting to evolving clinical workflows and end user needs.

Tariff Impact: Navigating Regulatory and Economic Dynamics

United States tariffs applied in 2025 on imported medical devices, semiconductor components, and cloud-based services have affected the economic landscape for AI-based diabetes management. Stakeholders are responding by exploring local manufacturing, diversifying supply chains, and innovating cost-effective sensor alternatives. Tariff-driven costs and operational changes have accelerated hybrid cloud adoption and prompted device makers to focus on modular, adaptable product designs. The shifting tariff environment has underscored the need for supply chain agility and collaboration across development and sourcing teams.

Methodology & Data Sources

This analysis uses a robust blend of primary research (interviews with endocrinologists, educators, regulators, and executives) and secondary research from journals, filings, and public disclosures. Data was triangulated and verified through expert consultation, direct clinical observation, and quantitative-statistical as well as qualitative-thematic analyses. Scenario planning further enriches forward-looking perspectives.

Why This Report Matters

  • Enables strategic planning by highlighting actionable trends, regulatory impacts, and technology adoption in the AI-powered diabetes management market.
  • Delivers segment-specific insight for effective resource allocation across device, technology, deployment, and regional priorities.
  • Equips executive teams with evidence-based findings to inform investment decisions, product development, and market entry strategies.

Conclusion

Artificial intelligence is advancing diabetes management from traditional models to adaptive, data-driven care. Senior decision-makers who prioritize interoperability, regulatory alignment, and collaborative innovation will be well-positioned to capitalize on future opportunities in this dynamic industry landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of continuous glucose monitoring data with AI predictive algorithms to personalize insulin dosing based on real-time lifestyle patterns
5.2. Deployment of machine learning models in wearable devices for early detection of hypoglycemic events among high-risk diabetic patients
5.3. Use of natural language processing in virtual health assistants to provide tailored dietary and medication advice for diabetic individuals
5.4. Development of federated learning frameworks to train AI diabetes management models across multiple institutions while preserving patient data privacy
5.5. Adoption of AI-driven smartphone applications for automated meal recognition and insulin bolus recommendations using computer vision techniques
5.6. Collaboration between pharma companies and tech firms to validate AI-enabled closed-loop insulin delivery systems in large-scale clinical trials
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Intelligence in Diabetes Management Market, by Device Type
8.1. Introduction
8.2. Blood Glucose Meter
8.2.1. Non Invasive Bg Meter
8.2.2. Smbg
8.3. Closed Loop System
8.3.1. Fully Closed Loop
8.3.2. Hybrid Closed Loop
8.4. Continuous Glucose Monitor
8.4.1. Intermittently Scanned Cgm
8.4.2. Real Time Cgm
8.5. Insulin Pump
8.5.1. Patch Pump
8.5.2. Tubed Pump
9. Artificial Intelligence in Diabetes Management Market, by Technology
9.1. Introduction
9.2. Cloud Computing
9.2.1. Private Cloud
9.2.2. Public Cloud
9.3. Decision Support Systems
9.3.1. Alert Generation
9.3.2. Dose Recommendation
9.4. Machine Learning
9.4.1. Reinforcement Learning
9.4.2. Supervised Learning
9.4.3. Unsupervised Learning
9.5. Mobile Applications
9.5.1. Android
9.5.2. Ios
9.6. Predictive Analytics
9.6.1. Glucose Trend Prediction
9.6.2. Risk Prediction
10. Artificial Intelligence in Diabetes Management Market, by End User
10.1. Introduction
10.2. Clinic
10.2.1. Diabetes Center
10.2.2. General Clinic
10.3. Home Care
10.3.1. Remote Monitoring
10.3.2. Self Monitoring
10.4. Hospital
10.4.1. Inpatient
10.4.2. Outpatient
10.5. Research Institute
10.5.1. Academic
10.5.2. Private
11. Artificial Intelligence in Diabetes Management Market, by Deployment Mode
11.1. Introduction
11.2. Cloud Based
11.2.1. Hybrid Cloud
11.2.2. Public Cloud
11.3. On Premise
11.3.1. Edge Computing
11.3.2. Server Based
12. Artificial Intelligence in Diabetes Management Market, by Type
12.1. Introduction
12.2. Gestational
12.2.1. First Trimester
12.2.2. Second Trimester
12.2.3. Third Trimester
12.3. Type 1
12.3.1. Adult Onset
12.3.2. Juvenile Onset
12.4. Type 2
12.4.1. Insulin Dependent
12.4.2. Non Insulin Dependent
13. Artificial Intelligence in Diabetes Management Market, by Component
13.1. Introduction
13.2. Hardware
13.2.1. Pumps
13.2.2. Sensors
13.2.3. Wearable Devices
13.3. Software
13.3.1. Algorithms
13.3.2. Data Management
13.3.3. User Interface
14. Americas Artificial Intelligence in Diabetes Management Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Artificial Intelligence in Diabetes Management Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Artificial Intelligence in Diabetes Management Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Medtronic plc
17.3.2. Abbott Laboratories
17.3.3. Dexcom, Inc.
17.3.4. F. Hoffmann-La Roche Ltd
17.3.5. Insulet Corporation
17.3.6. Tandem Diabetes Care, Inc.
17.3.7. Teladoc Health, Inc.
17.3.8. Omada Health, Inc.
17.3.9. Bigfoot Biomedical, Inc.
17.3.10. Glooko Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: RESEARCHAI
FIGURE 28. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: RESEARCHCONTACTS
FIGURE 30. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY NON INVASIVE BG METER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY NON INVASIVE BG METER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SMBG, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SMBG, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY FULLY CLOSED LOOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY FULLY CLOSED LOOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HYBRID CLOSED LOOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HYBRID CLOSED LOOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTERMITTENTLY SCANNED CGM, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTERMITTENTLY SCANNED CGM, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REAL TIME CGM, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REAL TIME CGM, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PATCH PUMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PATCH PUMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TUBED PUMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TUBED PUMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ALERT GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ALERT GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DOSE RECOMMENDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DOSE RECOMMENDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ANDROID, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ANDROID, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY IOS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY IOS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE TREND PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE TREND PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RISK PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RISK PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIABETES CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIABETES CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GENERAL CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GENERAL CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SELF MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SELF MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ACADEMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY EDGE COMPUTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY EDGE COMPUTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SERVER BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SERVER BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY FIRST TRIMESTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY FIRST TRIMESTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SECOND TRIMESTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SECOND TRIMESTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY THIRD TRIMESTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY THIRD TRIMESTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ADULT ONSET, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ADULT ONSET, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY JUVENILE ONSET, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY JUVENILE ONSET, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY NON INSULIN DEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY NON INSULIN DEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 179. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 180. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 181. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ALGORITHMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 182. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ALGORITHMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 183. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 184. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 185. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY USER INTERFACE, BY REGION, 2018-2024 (USD MILLION)
TABLE 186. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY USER INTERFACE, BY REGION, 2025-2030 (USD MILLION)
TABLE 187. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 188. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 223. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2024 (USD MILLION)
TABLE 224. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2025-2030 (USD MILLION)
TABLE 225. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 226. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 227. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 228. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 229. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, 2018-2024 (USD MILLION)
TABLE 230. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, 2025-2030 (USD MILLION)
TABLE 231. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, 2018-2024 (USD MILLION)
TABLE 232. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, 2025-2030 (USD MILLION)
TABLE 233. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, 2018-2024 (USD MILLION)
TABLE 234. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, 2025-2030 (USD MILLION)
TABLE 235. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 236. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 237. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
TABLE 238. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2025-2030 (USD MILLION)
TABLE 239. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 240. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 241. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKE

Samples

Sample File DOWNLOAD NOW

Companies Mentioned

  • Medtronic plc
  • Abbott Laboratories
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • Teladoc Health, Inc.
  • Omada Health, Inc.
  • Bigfoot Biomedical, Inc.
  • Glooko Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.04 Billion
Compound Annual Growth Rate30.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Diabetes Care Devices Market by Device Type, Technology, Delivery Mode, Insulin Type, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Diabetes Care Devices Market by Device Type, Technology, Delivery Mode, Insulin Type, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Digital Diabetes Management Market by Product Type (Glucose Monitoring Devices, Insulin Pumps, Mobile Apps), Delivery Method (Implantable Devices, Invasive Devices, Non Invasive Devices), End User, Application, Sales Channel - Global Forecast 2025-2030 - Product Image

Digital Diabetes Management Market by Product Type (Glucose Monitoring Devices, Insulin Pumps, Mobile Apps), Delivery Method (Implantable Devices, Invasive Devices, Non Invasive Devices), End User, Application, Sales Channel - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Digital Diabetes Management Market Size, Share & Trends Analysis Report By Product (Continuous Glucose Monitoring System, Smart Insulin Pen), By Type (Wearable, Handheld Device), By End-use (Hospitals), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Digital Diabetes Management Market Size, Share & Trends Analysis Report By Product (Continuous Glucose Monitoring System, Smart Insulin Pen), By Type (Wearable, Handheld Device), By End-use (Hospitals), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
EUR$5,950USDGBP
Artificial Intelligence (AI) in Diabetes Management - Global Strategic Business Report - Product Image

Artificial Intelligence (AI) in Diabetes Management - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
EUR$5,850USDGBP
Diabetes Care Devices - Global Strategic Business Report - Product Image

Diabetes Care Devices - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
EUR$5,850USDGBP

About the Artificial Intelligence in Diabetes Management Market

In the field of medical devices, the Artificial Intelligence in Diabetes Management market comprises a range of technologies aimed at assisting patients with diabetes and healthcare professionals to monitor, treat, and manage the disease more effectively. These include, but are not limited to, devices such as smart glucose meters, continuous glucose monitoring systems (CGMs), insulin pumps, and automated insulin delivery systems, all of which have incorporated AI algorithms to improve functionality. The integration of AI helps in predicting glucose levels fluctuations, offering personalized dosage recommendations, and identifying patterns in blood glucose data that may indicate a need for therapeutic adjustments. AI-driven solutions in this market are designed to ease the burden of daily diabetes management tasks, reduce the incidence of hypo- and hyperglycemic events, and overall improve the quality of life for people with diabetes. Advances in machine learning, predictive analytics, and data processing have greatly enhanced the performance of such devices, leading to more autonomous and patient-tailored diabetes care. Prominent companies operating in the Artificial Intelligence in Diabetes Management market include Medtronic, which offers AI-integrated insulin pumps and CGM systems; Dexcom, known for its sophisticated CGMs; Insulet Corporation, creator of the Omnipod insulin management system; and Abbott Laboratories, the company behind the FreeStyle Libre glucose monitoring technology. Other notable players include Tandem Diabetes Care and Diabnext, which have also developed innovative AI-driven medical devices and management platforms for diabetes care. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more